ATC Group: R05CB01 Acetylcysteine

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of R05CB01 in the ATC hierarchy

Level
Code
Title
1
Respiratory system
2
Cough and cold preparations
3
Expectorants, excl. combinations with cough suppressants
4
Mucolytics
5
R05CB01
Acetylcysteine

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route
Amount
ORAL - Oral
0.5 g
RESPIR - Respiratory (Inhalation) (solution)
1.6 g

Active ingredients in R05CB01

Active Ingredient
Description

Acetylcysteine is N-acetyl derivative of cysteine. Used as a mucolytic agent to reduce the viscosity of mucous secretions.

Medicines in this ATC group

Drug
Countries

Ecuador

United Kingdom

Hong Kong

Hong Kong

Austria

Ecuador

South Africa

Ecuador

Lithuania

Ecuador

Netherlands

Brazil Germany

Ecuador

Austria

France

Ecuador

Brazil Ecuador

Ecuador

Austria Brazil Ecuador Estonia France ...

South Africa

Finland

Ecuador

Singapore

Tunisia

Estonia

South Africa

Finland France

Ecuador

Singapore

Ireland United Kingdom

Lithuania Poland

Cyprus Hong Kong South Africa

Singapore

Singapore

Ecuador

Hong Kong Ireland

Cyprus Singapore

South Africa

Related product monographs

Title
Type
Country
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)
IE
Medication Package Insert (MPI)
ZA